# ELO Water In Diabetes Care For Enhancement Of Blood Sugar Control

> **NCT04127890** · NA · COMPLETED · sponsor: **Changi General Hospital** · enrollment: 150 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DIETARY_SUPPLEMENT:** ELO Water
- **DIETARY_SUPPLEMENT:** Placebo drinking water

## Key facts

- **NCT ID:** NCT04127890
- **Lead sponsor:** Changi General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-07
- **Primary completion:** 2018-05-28
- **Final completion:** 2018-05-28
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2020-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04127890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04127890, "ELO Water In Diabetes Care For Enhancement Of Blood Sugar Control". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04127890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*